Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Int J Cancer
    March 2024
  1. ATALLAH A, Grossman A, Nauman RW, Pare JF, et al
    Systemic versus localized Bacillus Calmette Guerin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
    Int J Cancer. 2024 Mar 14. doi: 10.1002/ijc.34897.
    >> Share

    September 2023
  2. PRADHAN P, Jia G, Khankari NK, Zheng W, et al
    Evaluating interactions of polygenic risk scores and NAT2 genotypes with tobacco smoking in bladder cancer risk.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34736.
    >> Share

  3. SJODAHL G, Eriksson P, Holmsten K, Abrahamsson J, et al
    Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.
    Int J Cancer. 2023 Sep 6. doi: 10.1002/ijc.34715.
    >> Share

    August 2023
  4. YU EY, Tang QY, Chen YT, Zhang YX, et al
    Genome-wide exploration of genetic interactions for bladder cancer risk.
    Int J Cancer. 2023 Aug 28. doi: 10.1002/ijc.34690.
    >> Share

    May 2023
  5. HOSSEINI B, Zendehdel K, Bouaoun L, Hall AL, et al
    Bladder cancer risk in relation to occupations held in a nationwide case-control study in Iran.
    Int J Cancer. 2023 May 9. doi: 10.1002/ijc.34560.
    >> Share

    March 2023
  6. HIEN TT, Ambite I, Wan MLY, Cavalera M, et al
    Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy.
    Int J Cancer. 2023 Mar 9. doi: 10.1002/ijc.34500.
    >> Share

    January 2023
  7. VIDRA N, Beeren I, van Zutphen M, Aben KK, et al
    Longitudinal associations of adherence to lifestyle recommendations and health-related quality of life in patients with non-muscle invasive bladder cancer.
    Int J Cancer. 2023 Jan 3. doi: 10.1002/ijc.34418.
    >> Share

    December 2022
  8. EINERHAND SMH, van Dijk N, van Dorp J, de Feijter JM, et al
    Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
    Int J Cancer. 2022;151:2004-2011.
    >> Share

    November 2022
  9. TAKAHASHI T
    Comments on "Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".
    Int J Cancer. 2022;151:1847-1848.
    >> Share

  10. EINERHAND SMH, van Dijk N, van der Heijden MS, van Rhijn BWG, et al
    Reply to: Comments on "Neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".
    Int J Cancer. 2022;151:1849-1850.
    >> Share

    August 2022
  11. KIM B, Jung M, Moon KC, Han D, et al
    Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34265.
    >> Share

    July 2022
  12. XIONG J, Yang L, Deng YQ, Yan SY, et al
    The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study.
    Int J Cancer. 2022 Jul 29. doi: 10.1002/ijc.34228.
    >> Share

    February 2022
  13. DIANATINASAB M, Wesselius A, Salehi-Abargouei A, Yu EYW, et al
    Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies.
    Int J Cancer. 2022 Feb 19. doi: 10.1002/ijc.33970.
    >> Share

    January 2022
  14. KARANOVIC S, Ardin M, Tang Z, Tomic K, et al
    Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure.
    Int J Cancer. 2022;150:374-386.
    >> Share

    September 2021
  15. OLAH C, Hahnen C, Nagy N, Musial J, et al
    A qPCR-based method for molecular subtype classification of urinary bladder cancer - stromal gene expressions show higher prognostic values than intrinsic tumor genes.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33809.
    >> Share

  16. LAI H, Cheng X, Liu Q, Luo W, et al
    Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
    Int J Cancer. 2021 Sep 3. doi: 10.1002/ijc.33794.
    >> Share

    March 2021
  17. TREVISANI F, Di Marco F, Raggi D, Bettiga A, et al
    Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the pure-01 study.
    Int J Cancer. 2021 Mar 15. doi: 10.1002/ijc.33554.
    >> Share

    February 2021
  18. VAN DOEVEREN T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, et al
    The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
    Int J Cancer. 2021;148:981-987.
    >> Share

    January 2021
  19. KOUTROS S, Decker KL, Baris D, Pardo LA, et al
    Bladder Cancer Risk Associated with Family History of Cancer.
    Int J Cancer. 2021 Jan 27. doi: 10.1002/ijc.33486.
    >> Share

    October 2020
  20. OZGUN G, Senturk S, Erkek-Ozhan S
    Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33374.
    >> Share

  21. WIECZOREK E, Garstka MA
    Recurrent Bladder Cancer in Aging Societies: Importance of Major Histocompatibility Complex Class I Antigen Presentation.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33359.
    >> Share

    June 2020
  22. XU T, Li HT, Wei J, Li M, et al
    Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype.
    Int J Cancer. 2020;146:3065-3076.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016